Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Lowered to $13.00 at Roth Mkm

Bioceres Crop Solutions (NASDAQ:BIOX) had its target price decreased by investment analysts at Roth Mkm from $15.00 to $13.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. Roth Mkm’s target price points to a potential upside of 51.16% from the stock’s current price.

BIOX has been the subject of a number of other reports. Canaccord Genuity Group restated a “buy” rating and issued a $17.00 price objective on shares of Bioceres Crop Solutions in a research note on Friday, July 19th. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Lake Street Capital cut their target price on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday. Oppenheimer cut their target price on shares of Bioceres Crop Solutions from $17.00 to $16.00 and set an “outperform” rating for the company in a research note on Wednesday. Finally, Roth Capital upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Tuesday, July 2nd. Four analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $13.63.

Bioceres Crop Solutions Stock Performance

BIOX stock opened at $8.60 on Wednesday. The company has a quick ratio of 0.83, a current ratio of 1.22 and a debt-to-equity ratio of 0.29. The company has a market capitalization of $540.05 million, a price-to-earnings ratio of 860.00 and a beta of 0.49. Bioceres Crop Solutions has a 12 month low of $8.16 and a 12 month high of $14.05. The firm has a 50 day moving average of $10.49 and a two-hundred day moving average of $11.45.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.23). Bioceres Crop Solutions had a return on equity of 0.28% and a net margin of 0.21%. The firm had revenue of $124.30 million during the quarter, compared to analyst estimates of $126.75 million. During the same quarter in the previous year, the firm posted ($0.06) earnings per share. As a group, equities analysts anticipate that Bioceres Crop Solutions will post 0.3 EPS for the current fiscal year.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of hedge funds have recently made changes to their positions in the business. Fourth Sail Capital LP raised its stake in shares of Bioceres Crop Solutions by 20.5% in the 2nd quarter. Fourth Sail Capital LP now owns 1,961,825 shares of the company’s stock valued at $21,992,000 after buying an additional 334,195 shares in the last quarter. Long Focus Capital Management LLC raised its stake in shares of Bioceres Crop Solutions by 19.9% in the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock valued at $3,145,000 after buying an additional 46,647 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Bioceres Crop Solutions by 3.1% in the 4th quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock valued at $3,253,000 after buying an additional 7,096 shares in the last quarter. Oak Family Advisors LLC raised its stake in shares of Bioceres Crop Solutions by 1.9% in the 2nd quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock valued at $728,000 after buying an additional 1,208 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in shares of Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after buying an additional 5,341 shares in the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.